Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients

Clinical data identified an association between the use of HMG-CoA reductase inhibitors (statins) and incident diabetes in patients with underlying diabetes risk factors such as obesity, hypertension and dysli...

Source: BMC Medical Genomics - June 3, 2019 Category: Genetics & Stem Cells Authors: Daniel Margerie, Philippe Lefebvre, Violeta Raverdy, Uwe Schwahn, Hartmut Ruetten, Philip Larsen, Alain Duhamel, Julien Labreuche, Doroth ée Thuillier, Bruno Derudas, Céline Gheeraert, Hélène Dehondt, Quentin Dhalluin, Jérémy Alexandre, Robert Caiaz Tags: Research article Source Type: research